{"id":3811,"date":"2019-11-19T07:51:13","date_gmt":"2019-11-19T07:51:13","guid":{"rendered":"https:\/\/www.nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\/"},"modified":"2019-11-19T07:51:13","modified_gmt":"2019-11-19T07:51:13","slug":"nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\/","title":{"rendered":"Nanexa tecknar avtal med amerikanskt l\u00e4kemedelsbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae"},"content":{"rendered":"
\n

<\/strong><\/span><\/p>\n<\/div>\n

Nanexa har idag signerat ett Material Transfer and Feasibility study Agreement med ett icke- namngivet globalt l\u00e4kemedelsf\u00f6retag lokaliserat i USA och dotterbolag till ett globalt japanskt l\u00e4kemedelsf\u00f6retag. F\u00f6retaget driver ett projekt i syfte att vidareutveckla en av sina nya tablettprodukter och skapa ett injicerbart l\u00e4kemedel som ska fris\u00e4tta aktiv substans under fyra veckor. M\u00e5let med det nu undertecknade avtalet \u00e4r att f\u00f6retaget ska genomf\u00f6ra en initial utv\u00e4rdering av PharmaShell<\/span>\u00ae\u00a0<\/span>som drug delivery-system f\u00f6r denna produkt.<\/span><\/p>\n

Avtalet reglerar bland annat detaljer om vad som ska unders\u00f6kas och klarg\u00f6rande om patentr\u00e4ttigheter samt \u00e4ven en fastlagd mindre ers\u00e4ttning som tillfaller Nanexa f\u00f6r denna utv\u00e4rdering.<\/span><\/p>\n

F\u00f6retagets VD David Westberg kommenterar:<\/span><\/p>\n

Det \u00e4r riktigt gl\u00e4djande att detta f\u00f6retag nu vill starta en utv\u00e4rdering av PharmaShell<\/span>\u00ae\u00a0<\/span>f\u00f6r ett av sina viktiga Life Cycle Management-projekt. Vi ser fram emot att p\u00e5b\u00f6rja det praktiska arbetet s\u00e5 snart som m\u00f6jligt och att vi inom en snar framtid kan generera resultat som kan ligga till grund f\u00f6r ett potentiellt djupare och l\u00e4ngre produktutvecklingsavtal.<\/span><\/p>\n

F\u00f6r mer information kontakta:
David Westberg\u00a0<\/span>\u2013\u00a0<\/span>VD, Nanexa AB (publ)<\/span>\u00a0Telefon: 0709 -42 83 03<\/span>
<\/span>E-post: david.westberg@nanexa.se www.nanexa.com<\/span><\/p>\n

Om Nanexa AB (publ)<\/span><\/p>\n

Nanexa AB \u00e4r ett nanoteknologiskt drug delivery-f\u00f6retag som fokuserar p\u00e5 utvecklingen av PharmaShell<\/span>\u00ae\u00a0<\/span>som \u00e4r ett nytt och banbrytande drug delivery-system som bed\u00f6ms ha en stor potential inom ett flertal substanstyper och indikationsomr\u00e5den. Inom ramen f\u00f6r PharmaShell<\/span>\u00ae<\/span>utvecklar Nanexa egna projekt och har samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland AstraZeneca.<\/span><\/p>\n

\n

Bifogade filer<\/strong><\/p>\n\n

Release<\/a><\/p>\n<\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"<\/p>\n

Nanexa har idag signerat ett Material Transfer and Feasibility study Agreement med ett icke- namngivet globalt l\u00e4kemedelsf\u00f6retag lokaliserat i USA och dotterbolag till ett globalt japanskt l\u00e4kemedelsf\u00f6retag.<\/p>\n

L\u00e4s mer<\/a><\/p>\n","protected":false},"template":"","class_list":["post-3811","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"\nNanexa tecknar avtal med amerikanskt l\u00e4kemedelsbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa tecknar avtal med amerikanskt l\u00e4kemedelsbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa har idag signerat ett Material Transfer and Feasibility study Agreement med ett icke- namngivet globalt l\u00e4kemedelsf\u00f6retag lokaliserat i USA och dotterbolag till ett globalt japanskt l\u00e4kemedelsf\u00f6retag.L\u00e4s mer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\\\/\",\"name\":\"Nanexa tecknar avtal med amerikanskt l\u00e4kemedelsbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2019-11-19T07:51:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa tecknar avtal med amerikanskt l\u00e4kemedelsbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa tecknar avtal med amerikanskt l\u00e4kemedelsbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa tecknar avtal med amerikanskt l\u00e4kemedelsbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB","og_description":"Nanexa har idag signerat ett Material Transfer and Feasibility study Agreement med ett icke- namngivet globalt l\u00e4kemedelsf\u00f6retag lokaliserat i USA och dotterbolag till ett globalt japanskt l\u00e4kemedelsf\u00f6retag.L\u00e4s mer","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\/","name":"Nanexa tecknar avtal med amerikanskt l\u00e4kemedelsbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2019-11-19T07:51:13+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-tecknar-avtal-med-amerikanskt-lakemedelsbolag-for-utvardering-av-pharmashell\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa tecknar avtal med amerikanskt l\u00e4kemedelsbolag f\u00f6r utv\u00e4rdering av PharmaShell\u00ae"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/3811","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=3811"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}